77 related articles for article (PubMed ID: 8110561)
1. Fentanyl inhibits the release of [3H]noradrenaline from SH-SY5Y human neuroblastoma cells.
Atcheson R; Rowbotham DJ; Lambert DG
Br J Anaesth; 1994 Jan; 72(1):98-103. PubMed ID: 8110561
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl inhibits the uptake of [3H]noradrenaline in cultured neuronal cells.
Atcheson R; Rowbotham DJ; Lambert DG
Br J Anaesth; 1993 Oct; 71(4):540-3. PubMed ID: 8260304
[TBL] [Abstract][Full Text] [Related]
3. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
Murphy NP; McCormack JG; Ball SG; Vaughan PF
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
[TBL] [Abstract][Full Text] [Related]
4. Etomidate inhibits [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells.
Sikand KS; Hirota K; Smith G; Lambert DG
Neurosci Lett; 1997 Oct; 236(2):87-90. PubMed ID: 9404818
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.
McDonald RL; Vaughan PF; Peers C
Br J Pharmacol; 1994 Oct; 113(2):621-7. PubMed ID: 7834216
[TBL] [Abstract][Full Text] [Related]
6. Potassium- and carbachol-evoked release of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y.
Murphy NP; Ball SG; Vaughan PF
J Neurochem; 1991 May; 56(5):1810-5. PubMed ID: 1901596
[TBL] [Abstract][Full Text] [Related]
7. Dual regulation by opioids of 3H-norepinephrine release in the human neuroblastoma cell-line SK-N-SH.
Keren O; Garty M; Sarne Y
Brain Res; 1994 May; 646(2):319-23. PubMed ID: 8069682
[TBL] [Abstract][Full Text] [Related]
8. Effects of morphine and its metabolites on opiate receptor binding, cAMP formation and [3H]noradrenaline release from SH-SY5Y cells.
Lambert DG; Atcheson R; Hirst RA; Rowbotham DJ
Biochem Pharmacol; 1993 Oct; 46(7):1145-50. PubMed ID: 8216364
[TBL] [Abstract][Full Text] [Related]
9. Effects of propofol and thiopentone on potassium- and carbachol-evoked [3H]noradrenaline release and increased [Ca2+]i from SH-SY5Y human neuroblastoma cells.
Lambert DG; Willets JM; Atcheson R; Frost C; Smart D; Rowbotham DJ; Smith G
Biochem Pharmacol; 1996 Jun; 51(12):1613-21. PubMed ID: 8687476
[TBL] [Abstract][Full Text] [Related]
10. Effect of halothane on K+ and carbachol stimulated [3H]noradrenaline release and increased [Ca2+]i in SH-SY5Y human neuroblastoma cells.
Atcheson R; Bjornstrom K; Hirst RA; Rowbotham DJ; Lambert DG
Br J Anaesth; 1997 Jul; 79(1):78-83. PubMed ID: 9301393
[TBL] [Abstract][Full Text] [Related]
11. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
12. The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
Murphy NP; Ball SG; Vaughan PF
Neurosci Lett; 1991 Aug; 129(2):229-32. PubMed ID: 1745405
[TBL] [Abstract][Full Text] [Related]
13. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
Zadina JE; Chang SL; Ge LJ; Kastin AJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibitors of eicosanoid metabolism on release of [3H]noradrenaline from the human neuroblastoma, SH-SY5Y.
Vaughan PF; Murphy MG; Ball SG
J Neurochem; 1993 Apr; 60(4):1365-71. PubMed ID: 8455030
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy mu-opioids.
Ammer H; Schulz R
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):263-71. PubMed ID: 8216227
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to mu-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5'-O-(3-[35S]-thio)triphosphate binding.
Elliott J; Guo L; Traynor JR
Br J Pharmacol; 1997 Aug; 121(7):1422-8. PubMed ID: 9257923
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of [3H]-noradrenaline release from SH-SY5Y cells: the role of Ca2+ and cyclic AMP.
Atcheson R; Lambert DG; Hirst RA; Rowbotham DJ
Br J Pharmacol; 1994 Mar; 111(3):787-92. PubMed ID: 8019757
[TBL] [Abstract][Full Text] [Related]
18. Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells.
Ehrich M; Intropido L; Costa LG
J Toxicol Environ Health; 1994 Sep; 43(1):51-63. PubMed ID: 8078092
[TBL] [Abstract][Full Text] [Related]
19. Do nitrous oxide and halothane influence opioid receptor binding in SH-SY5Y human neuroblastoma cells?
Campbell DJ; Rowbotham DJ; Lambert DG
Br J Anaesth; 1995 Dec; 75(6):752-5. PubMed ID: 8672325
[TBL] [Abstract][Full Text] [Related]
20. Fentanyl increases intracellular Ca2+ concentrations in SH-SY5Y cells.
Wandless AL; Smart D; Lambert DG
Br J Anaesth; 1996 Mar; 76(3):461-3. PubMed ID: 8785153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
